Xellera Therapeutics is a specialized CDMO dedicated to Cell and Gene Therapy (CGT) and Advanced Therapy Products (ATP). The company provides GMP-compliant manufacturing services that span early development, clinical production, and commercial-scale supply. By integrating technical expertise, scalable processes, and strong regulatory alignment, Xellera Therapeutics helps accelerate the successful delivery of advanced therapies to patients globally.